1.29
-0.12 (-8.51%)
-0.12 (-8.51%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.185
High
4.4696
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Jaguar Health Inc | JAGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.12 | -8.51% | 1.29 | 00:00:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.34 | 1.20 | 1.34 | 1.30 | 1.41 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.321 | 2.15 | 1.83 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 22,899 | 15,510,470 | $ 1.25 | $ 19,395,080 | 94,803,377 | 0.185 - 4.4696 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:45 | formt | 200 | $ 1.29 | USD |
Jaguar Health Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 151.98M | 117.82M | 117.62M | $ 5.78M | $ - | -29.59 | 1.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Jaguar Health News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JAGX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.9002 | 1.92 | 1.20 | 1.62 | 5,753,580 | -0.6102 | -32.11% |
| 1 Month | 2.05 | 2.18 | 1.20 | 1.85 | 6,009,595 | -0.76 | -37.07% |
| 3 Months | 3.14 | 3.63 | 1.20 | 2.55 | 14,040,211 | -1.85 | -58.92% |
| 6 Months | 0.3045 | 4.4696 | 0.185 | 1.85 | 37,237,660 | 0.9855 | 323.65% |
| 1 Year | 0.588 | 4.4696 | 0.185 | 1.69 | 20,701,857 | 0.702 | 119.39% |
| 3 Years | 12.60 | 224.00 | 0.185 | 5.29 | 8,217,389 | -11.31 | -89.76% |
| 5 Years | 103.60 | 265.30 | 0.185 | 7.95 | 5,802,493 | -102.31 | -98.75% |
Jaguar Health Description
| Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. It operates into two business segments namely Human health and animal health. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. |
